Precision Antibody

Purified monoclonal antibody against the SARS-CoV-2 nucleocapsid protein, supplied in PBS.

Antibodies targeting the RBD region of the SARS-CoV-2 S1 protein.

Antibodies targeting the SARS-CoV-2 Nucleocapsid protein.

Monoclonal antibody targeting GP88 / Progranulin clone 6B3.

Comprehensive custom polyclonal antibody production service including antigen preparation, multi-species immunization, affinity purification, and quality verification.

Custom generation of monoclonal antibodies tailored to specific targets, antigen formats, and application requirements.

Anti-Human ACE2 Protein Monoclonal Antibody supplied as 100 µg purified antibody in PBS, pH 7.4, suitable for Protein Simple Wes, Western blot, ELISA, and immunoprecipitation.

Antibodies targeting human ACE2 protein.

Sample pack of anti-HRP2 mouse monoclonal antibodies validated for ELISA and designed for malaria research and diagnostics targeting Plasmodium falciparum histidine-rich protein 2.

Mouse monoclonal antibody targeting Plasmodium falciparum histidine-rich protein 2 (HRP2), useful for malaria research and rapid diagnostic test development.

Monoclonal antibody targeting HRP2 clone 11E10 for malaria and research.

Monoclonal antibody targeting HRP2 clone 6C8.

Monoclonal antibody targeting HRP2 clone 10F5.

Fully human antibody development using transgenic mice and proprietary procedures to rapidly generate specific therapeutic monoclonal antibodies producing fully human IgG.

Sequencing service for variable heavy and light chains of antibodies.

Cloning service for variable heavy and light chains of antibodies.

Anti-COV2 Neutralizing Monoclonal Antibodies offered by Precision Antibody.

Mouse monoclonal antibody targeting the Androgen Receptor Variant 7 (AR-V7), designed for research applications such as Western Blot and Immunohistochemistry.

Rapid novel monoclonal antibody development service using proprietary procedures and platform to generate application-specific mAbs in 40-60 days.

Monoclonal antibody targeting MYC for research.

Scalable monoclonal antibody expression and purification services delivering up to gram quantities.

Monoclonal antibody targeting MAP1S for research.

Monoclonal antibody targeting 6x Histidine tags.

Comprehensive antibody production and purification services ranging from milligram to gram scale using hybridomas, stable cell lines, transiently transfected cells, and ascites.

Small scale to large scale production of monoclonal antibodies from hybridoma cells, CHO cells, and HEK293 cells based on culture medium volume or antibody amount.

Comprehensive antibody characterization services to evaluate binding kinetics, affinity, isotype, epitope behavior, and molecular characteristics of candidate clones.

Custom assay development services for biochemical and molecular characterization.

Custom antibody gene cloning, expression vector construction, and recombinant antibody production services in CHO or HEK293 cells, scaling from milligrams to grams.

Custom polyclonal antibody development services.

Traditional rabbit polyclonal antibody development services with 60 or 90-day protocols and optional continuous production and purification services.

Specialized custom development of monoclonal antibodies recognizing unique determinants in the variable region of a therapeutic drug antibody for pharmacokinetic (PK) and anti-drug antibody (ADA) studies.

Development of various enzyme immunoassays including label conjugation to primary antibodies, LLD/LLQ optimization, and manufacturing of ready-to-use sandwich ELISA kit prototypes.

Custom cell line development services to support antibody expression and production workflows.

Custom antibody humanization service designed to modify nonhuman antibody sequences to contain a greater proportion of human antibody sequence while preserving antigen recognition characteristics.

Service to generate master and working cell banks from early passage hybridoma clones to ensure stable antibody characteristics and production rates.

Precision Antibody offers a robust humanization process using the 5x5 Method, generating 25 unique combinations of humanized antibodies through techniques covering CDR and Framework Regions.

Label-free binding kinetics analysis service utilizing Octet and Biacore platforms to help select the right antibodies, determine binding parameters, and provide actionable affinity data for research programs.

Service for mapping the binding site of an antibody.

Binding kinetics and affinity analysis services using Octet and Biacore platforms.

Reverse engineering service of human antibodies to generate mouse monoclonal counterparts.

Expertise in developing anti-idiotypic antibodies that specifically target the variable regions of drug antibodies for pharmacokinetic (PK) studies.

Antibody labeling service utilizing enzymes, fluorochromes, sulfo-tag, and biotin for detection purposes.

Assay service for antibody class and subclass determination.

Assay service for determining the isoelectric point of monoclonal antibodies.

Precision Antibody offers professional antibody purification services utilizing affinity purification methods (Protein A, G, A/G, L, or Mellon), antigen affinity columns, as well as classical IEC and SEC purification.

Antibody internalization assay and development services.

Sequencing service to determine the variable region sequence of human antibodies using Illumina MiSeq technology.

Validation service to ensure consistent performance, degradation resistance, and aggregation monitoring of purified antibodies over time.

Binding inhibition assays using Octet, ELISA, or functional assays to identify antibodies that block ligand binding, protein-protein interactions, or signal transduction.

Assay service for detecting oligomers using analytical size-exclusion chromatography.

Technique utilizing dye- or enzyme-linked antibodies for precise microscopic detection and localization of antigens within tissue samples to assess expression levels.

A series of in vitro and in vivo biological assays incorporated into preclinical efficacy testing to ensure therapeutic antibodies are biologically effective.

Flow cytometry-based binding assays using a high throughput Intellicyt flow cytometer for screening and validating antibodies against plasma membrane-associated targets.

A screening tool consisting of human cancer cell lines sourced from ATCC and developed in-house, categorized by cancer type and drug sensitivity or resistance.